Oncology Information System Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Global Oncology Information System Market Trends and Insights

Rising Incidence of Cancer Worldwide

Global cancer burden continues to climb, with 1.7 million new cases diagnosed each year in the United States alone, placing unprecedented demands on data management and care coordination ^{[1]Roberto Casale, “Predicting Risk of Metastases and Recurrence in Soft-Tissue Sarcomas via Radiomics and Formal Methods,” JAMIA Open, academic.oup.com}. Oncology workflows now incorporate genomic sequencing, multi-modal imaging, and real-world evidence, all of which require an integrated platform capable of supporting personalized medicine. Improved survival rates—up 33% over three decades—have created a growing cohort of cancer survivors who need long-term monitoring, further stretching information infrastructure ^{[2]Xue Qin Yu, “Crude Probability of Death for Cancer Patients by Spread of Disease in New South Wales, Australia 1985 to 2014,” Cancer Medicine, onlinelibrary.wiley.com}. Demographic shifts toward aging populations amplify these pressures, pushing healthcare organizations to scale oncology information system market deployments that support multidisciplinary teams and lifelong care pathways.

Government Funding for Oncology IT Modernization

Public-sector investment is accelerating adoption of advanced cancer informatics. The United States Cancer Moonshot allocates targeted funds for standardized oncology data elements across electronic health records, while the CDC’s AIMS platform and NOAH hub bring real-time pathology and laboratory analytics to state cancer registries. New York State committed USD 188 million to hospital modernization, prioritizing integrated cancer programs. The United Kingdom set aside GBP 2 billion for Cancer 360 technology, creating unified oncology information layers across NHS institutions ^{[3]United Kingdom Department of Health and Social Care, “Cancer 360 Investment,” gov.uk}. Such initiatives tighten interoperability rules and stimulate private investment, reinforcing growth in the oncology information system market.

Interoperability Mandates (21st Century Cures Act)

The Cures Act final rule requires FHIR R4.0.1 APIs and USCDI compliance, compelling oncology vendors to expose standardized endpoints and eliminate information-blocking practices. Six major health-IT suppliers pledged USCDI+ Cancer support in 2024, unlocking granular data exchange that spans pathology, genomics, and treatment response. Oncology practices now automate data submissions for clinical trials and quality metrics, replacing slow manual uploads. Open API architectures therefore become a competitive differentiator across the oncology information system market.

AI-Driven Clinical Decision Support Boosting ROI

Artificial intelligence is proving its value in frontline cancer care. Microsoft’s agentic orchestrator, piloted at Stanford and Johns Hopkins, links radiology, pathology, staging, and guidelines agents inside existing collaboration suites, shortening tumor board prep times. Memorial Sloan Kettering leverages AWS to process vast imaging and genomic data for bespoke treatment plans. Ontada reports that AI-enabled natural language processing unlocks up to 80% of critical patient details buried in unstructured notes, transforming research and reimbursement workflows. GPT-4 models achieved 84% accuracy in interpreting oncology guidelines using retrieval-augmented generation, indicating tangible gains in evidence-based decision support.

High Total Cost of Ownership & Implementation

Community oncology practices must weigh capital outlays against long-term savings. Mayo Clinic’s automated dose rounding study showed potential savings of USD 39.75 million over three years yet required sizable upfront investment for technology, training, and system maintenance. The Enhancing Oncology Model adds reporting and care-management obligations that strain smaller clinics. Cost-benefit frameworks underline non-financial gains—improved safety, fewer adverse events, and higher staff productivity—yet the cash flow challenge remains acute until reimbursement adjusts.

Shortage of Oncology-Informatics Professionals

The United States anticipates a shortfall exceeding 2,000 oncologists and hematologists by end-2025, with rural communities most affected. Demand for oncology services grew 40% from 2012 to 2025, but workforce supply rose only 25%. Training pipelines for data specialists are expanding through NAACCR and AHIMA programs, though results will take years to materialize. The scarcity of cancer informatics talent constrains configuration, optimization, and support for oncology information system market deployments, especially at smaller facilities.

Segment Analysis

By Product & Service: Services Lead Implementation Complexity

Services held 51.01% of oncology information system market share in 2024 as hospitals and clinics relied on implementation partners for workflow mapping, system configuration, training, and ongoing support. Cardinal Health’s USD 1.1 billion purchase of Integrated Oncology Network illustrates how bundled professional services amplify adoption and stickiness for enterprise clients. The oncology information system market size for services is projected to expand in tandem with growing proton-therapy and CAR-T monitoring deployments that demand bespoke integrations. 

Software is the fastest-growing component, tracking an 8.98% CAGR through 2030. GE HealthCare’s CareIntellect for Oncology consolidates treatment history and decision support into a single dashboard, cutting data-gathering time from hours to minutes. RaySearch Laboratories integrates plan-quality analytics into RayCare, showing how vendors differentiate on AI-enabled automation. Consulting, maintenance, and managed-service subsegments rise as providers outsource FHIR upgrades, cloud migrations, and cybersecurity hardening. The result is a blended revenue model in which software licensing and recurring services generate predictable cash flows across the oncology information system market.

Note: Segment shares of all individual segments available upon report purchase

By Application: Medical Oncology Dominance Faces Radiation Acceleration

Medical oncology commands 47.82% of the oncology information system market size, reflecting the complexity of systemic therapy scheduling, adverse-event monitoring, and longitudinal outcomes tracking. Platforms ingest laboratory values, biomarkers, and prior authorizations to streamline chemotherapy administration and reimbursement. Radiation oncology, however, posts the quickest trajectory at a 9.12% CAGR thanks to expanding proton-therapy centers and adaptive radiotherapy techniques that require precise data orchestration. 

Clinical studies show pencil-beam scanning proton therapy with static apertures improved conformity index by 15.3% and reduced dose gradients by 17.6%, underscoring the need for real-time plan adjustment. Vendors such as Elekta embed MIM Software into treatment workflows, merging imaging, planning, and follow-up data. Surgical oncology applications are also integrating, enabling tumor boards to view pre-operative imaging, operative notes, and adjuvant therapy plans in one workspace. This convergence supports multidisciplinary care pathways critical to value-based models and cements broader platform uptake across the oncology information system market.

By End User: Hospital Systems Leverage Scale Advantages

Hospital systems represented 71.45% of revenue in 2024, deploying enterprise oncology platforms that span inpatient, outpatient, and research settings. Memorial Sloan Kettering, for instance, pairs AWS analytics with AI-assisted note-taking from Abridge to accelerate documentation and clinical research. Large networks negotiate favorable pricing, support service integration, and secure data-center redundancies, enhancing system reliability. 

Oncology clinics, growing at 9.45% CAGR, pivot toward cloud-hosted solutions that reduce capital expenditure and comply with value-based initiatives. The American Oncology Network realized nearly USD 6 million in Medicare savings during its first Enhancing Oncology Model performance period by harnessing real-time dashboards for quality measures. Academic centers and community practices join consortia like OneOncology to access shared technical infrastructure and data science teams, demonstrating how affiliation strategies spread costs and extend advanced capabilities. Such dynamics foster widespread yet differentiated adoption across the oncology information system market.

Note: Segment shares of all individual segments available upon report purchase

Geography Analysis

North America accounted for 45.23% of oncology information system market share in 2024, supported by the Cures Act interoperability mandate, robust reimbursement mechanisms, and well-established electronic health record penetration. Federal programs such as the CDC’s data-modernization initiative accelerate real-time cancer surveillance, nudging providers toward cloud-first architectures. Academic centers partner with technology firms to pioneer AI solutions, reinforcing the region’s leadership stance.

Asia-Pacific is the fastest-growing region, projecting a 9.85% CAGR through 2030. China’s Trinity smart-hospital blueprint outlines standards for unified EMRs and smart services, positioning local health systems to leapfrog legacy architectures ^{[4]Jorge A. Jiménez-Oré, “Pencil-Beam Scanning Proton Therapy with Static Apertures: Dosimetric Benefits in Clinical Implementation,” Frontiers in Oncology, frontiersin.org}. South Korea’s K-CURE Public Cancer Library aggregates anonymized records for 2.26 million patients, while a USD 25 million government fund backs AI-driven drug discovery. Japan’s medical DX program builds a national information platform to unify patient data, and India’s All India Institute of Medical Sciences deploys AI image analytics to detect breast and ovarian cancers earlier. These coordinated efforts tighten standards, ease procurement, and seed demand across the oncology information system market.

Europe follows with pan-regional initiatives such as the European Cancer Imaging Initiative and JANE project, which create federated networks for imaging data and AI tool validation. Member states co-invest in cloud-based registries and shared analytics, encouraging vendors to certify FHIR readiness and GDPR compliance. Middle East & Africa and Latin America show incremental adoption, often through public-private partnerships that bundle tele-oncology, remote monitoring, and basic EMR upgrades as foundational steps toward a full oncology information system market rollout.